Carl Roos

518 total citations
13 papers, 423 citations indexed

About

Carl Roos is a scholar working on Oncology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carl Roos has authored 13 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pharmaceutical Science and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carl Roos's work include Drug Transport and Resistance Mechanisms (8 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (7 papers). Carl Roos is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (7 papers). Carl Roos collaborates with scholars based in Sweden, Germany and United States. Carl Roos's co-authors include Hans Lennernäs, David Dahlgren, Erik Sjögren, Christer Tannergren, Bertil Abrahamsson, Anders Lundqvist, Mitsuru Hashida, Hitoshi Sezaki, Per M. Hellström and Yoshinobu Takakura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Pharmaceutics.

In The Last Decade

Carl Roos

13 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Roos Sweden 10 232 182 88 45 39 13 423
Benjamin Wuyts Belgium 7 214 0.9× 104 0.6× 56 0.6× 54 1.2× 30 0.8× 11 341
Omri Wolk Israel 9 159 0.7× 120 0.7× 51 0.6× 49 1.1× 41 1.1× 9 357
Eva Persson Sweden 6 347 1.5× 192 1.1× 100 1.1× 85 1.9× 66 1.7× 7 567
F. Ingels Belgium 6 232 1.0× 195 1.1× 71 0.8× 58 1.3× 56 1.4× 6 402
Philippe Berben Belgium 10 279 1.2× 94 0.5× 108 1.2× 73 1.6× 27 0.7× 11 434
Gunilla Hanisch Sweden 4 370 1.6× 134 0.7× 92 1.0× 103 2.3× 49 1.3× 4 507
Danny Riethorst Belgium 9 259 1.1× 112 0.6× 89 1.0× 66 1.5× 35 0.9× 12 447
A.‐L. Ungell Sweden 5 221 1.0× 237 1.3× 70 0.8× 72 1.6× 74 1.9× 9 434
Masayuki Akimoto Japan 12 169 0.7× 94 0.5× 129 1.5× 35 0.8× 29 0.7× 39 490
Sara Carlert Sweden 6 392 1.7× 99 0.5× 78 0.9× 66 1.5× 60 1.5× 12 512

Countries citing papers authored by Carl Roos

Since Specialization
Citations

This map shows the geographic impact of Carl Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Roos more than expected).

Fields of papers citing papers by Carl Roos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Roos. The network helps show where Carl Roos may publish in the future.

Co-authorship network of co-authors of Carl Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Roos. A scholar is included among the top collaborators of Carl Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Roos. Carl Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mårtensson, Linda, Monika Semmrich, Carl Roos, et al.. (2020). 725 Pre-clinical development of TNFR2 ligand-blocking BI-1808 for cancer immunotherapy. SHILAP Revista de lepidopterología. A434.1–A434. 7 indexed citations
2.
Josefson, Mats, Magnus Fransson, Jonas Wilbs, et al.. (2020). Quantification of surface composition and surface structure of inhalation powders using TOF-SIMS. International Journal of Pharmaceutics. 587. 119666–119666. 16 indexed citations
3.
4.
Roos, Carl. (2018). Intestinal absorption of drugs : The impact of regional permeability, nanoparticles, and absorption-modifying excipients. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations
5.
Roos, Carl, David Dahlgren, Jan Westergren, et al.. (2017). In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations. Molecular Pharmaceutics. 14(12). 4233–4242. 50 indexed citations
6.
Dahlgren, David, Carl Roos, Anders Lundqvist, et al.. (2017). Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker51Cr-EDTA. Molecular Pharmaceutics. 14(12). 4243–4251. 31 indexed citations
7.
Roos, Carl, David Dahlgren, Erik Sjögren, et al.. (2017). Regional Intestinal Permeability in Rats: A Comparison of Methods. Molecular Pharmaceutics. 14(12). 4252–4261. 43 indexed citations
8.
Dahlgren, David, Carl Roos, Anders Lundqvist, et al.. (2016). Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms. Molecular Pharmaceutics. 13(9). 3022–3033. 30 indexed citations
9.
Dahlgren, David, Carl Roos, Anders Lundqvist, et al.. (2016). Regional Intestinal Permeability of Three Model Drugs in Human. Molecular Pharmaceutics. 13(9). 3013–3021. 56 indexed citations
10.
Roos, Carl, David Dahlgren, Filippos Kesisoglou, et al.. (2016). Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs. Drug Development and Industrial Pharmacy. 43(2). 338–346. 12 indexed citations
11.
Sjögren, Erik, David Dahlgren, Carl Roos, & Hans Lennernäs. (2015). Humanin VivoRegional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data. Molecular Pharmaceutics. 12(6). 2026–2039. 52 indexed citations
12.
Dahlgren, David, Carl Roos, Erik Sjögren, & Hans Lennernäs. (2014). Direct In Vivo Human Intestinal Permeability (Peff) Determined with Different Clinical Perfusion and Intubation Methods. Journal of Pharmaceutical Sciences. 104(9). 2702–2726. 86 indexed citations
13.
Roos, Carl, Satoshi Matsumoto, Yoshinobu Takakura, Mitsuru Hashida, & Hitoshi Sezaki. (1984). Physicochemical and antitumor characteristics of some polyamino acid prodrugs of mitomycin C. International Journal of Pharmaceutics. 22(1). 75–87. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Wuyts Breakdown of academic impact, for papers by Omri Wolk Breakdown of academic impact, for papers by Eva Persson Breakdown of academic impact, for papers by F. Ingels Breakdown of academic impact, for papers by Philippe Berben Breakdown of academic impact, for papers by Gunilla Hanisch Breakdown of academic impact, for papers by Danny Riethorst Breakdown of academic impact, for papers by A.‐L. Ungell Breakdown of academic impact, for papers by Masayuki Akimoto Breakdown of academic impact, for papers by Sara Carlert
Rankless by CCL
2026